Emphasising their desire
to move the drug forward, in a separate announcement made
directly to the HD community, Ionis said «Upon study completion, the
next step for this program will be
to conduct a study
to investigate if decreasing mutant huntingtin protein with IONIS - HTTRx can slow the progression of this terrible disease.»